NEW YORK — Mainz Biomed said on Thursday that it has signed an agreement for the distribution of its ColoAlert at-home colorectal cancer screening test in Germany with Praxisdienst.
According to Mainz, Praxisdienst is Germany's largest online medical products retailer. Financial and other terms of the deal were not disclosed.
ColoAlert analyzes stool samples collected at home, combining PCR-based DNA and RNA analysis with fecal immunohistochemistry for the early detection of colorectal cancer and precancerous lesions.
Earlier this week, Mainzinkeda similar distribution pact with TomaLab for Italy. The German company also recentlyreleasedpositive interim data on a next-generation version of the assay.
